20619-13-0

• 常用中文名：N,N-didemethylchlorpheniramine
• 常用英文名：N,N-didemethylchlorpheniramine
• CAS号：20619-13-0
• 分子式：C₁₄H₁₅ClN₂
• 分子量：246.73500
• 发布时间：2017-01-27 05:19:05
• 更新时间：2025-08-25 02:10:37

名称

• 英文名: 3-(4-chlorophenyl)-3-pyridin-2-ylpropan-1-amine
• 英文别名: N,N-Didemethylchlorpheniramine; DDCP; Didesmethylchlorpheniramine

物化性质

• 密度: 1.166g/cm3
• 沸点: 374ºC at 760mmHg
• 分子式: C₁₄H₁₅ClN₂
• 分子量: 246.73500
• 闪点: 180ºC
• 精确质量: 246.09200
• PSA: 38.91000
• LogP: 3.91600
• 蒸汽压: 8.6E-06mmHg at 25°C
• 折射率: 1.589

安全

• 海关编码: 2933399090

合成路线

405551-70-4 ~36% 20619-13-0

文献：Aslanian, Robert; Mutahi, Mwangi Wa; Shih, Neng-Yang; Piwinski, John J.; West, Robert; Williams, Shirley M.; She, Susan; Wu, Ren-Long; Hey, John A. Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 12 p. 1959 - 1961

6318-51-0 ~% 20619-13-0

文献：Aslanian, Robert; Mutahi, Mwangi Wa; Shih, Neng-Yang; Piwinski, John J.; West, Robert; Williams, Shirley M.; She, Susan; Wu, Ren-Long; Hey, John A. Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 12 p. 1959 - 1961

405551-69-1 ~% 20619-13-0

文献：Aslanian, Robert; Mutahi, Mwangi Wa; Shih, Neng-Yang; Piwinski, John J.; West, Robert; Williams, Shirley M.; She, Susan; Wu, Ren-Long; Hey, John A. Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 12 p. 1959 - 1961

122376-81-2 ~% 20619-13-0

文献：Buschauer, Armin Archiv der Pharmazie (Weinheim, Germany), 1989 , vol. 322, p. 165 - 171

109-09-1 ~% 20619-13-0

文献：Buschauer, Armin Archiv der Pharmazie (Weinheim, Germany), 1989 , vol. 322, p. 165 - 171

5005-37-8 ~% 20619-13-0

文献：Buschauer, Armin Archiv der Pharmazie (Weinheim, Germany), 1989 , vol. 322, p. 165 - 171

140-53-4 ~% 20619-13-0

文献：Buschauer, Armin Archiv der Pharmazie (Weinheim, Germany), 1989 , vol. 322, p. 165 - 171

上下游产品

上游产品  5
6318-51-0 122376-81-2 109-09-1 5005-37-8
140-53-4
下游产品  0

海关

海关编码	2933399090
中文概述	2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
Summary	2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%